Business Type Manufacturing
Year Established 2008
Main Markets Americas,Africa,Asia,Caribbean,America,East Europe
Main Products Alarelinacetate, Angiotensin Acetate,Argipressin Acetate,Atosiban Acetate,Bivalirudin Trifluoroacetate, Cetrorelix Acetate,Deslorelin Acetate,Desmopressin Acetate,Elcatonin Acetate,Enfuvirtide Acetate,Eptifibatide Acetate, Exenatide Acetate,Glp-1,
Country/Region China
Company Introduction
Shanghai Taishi Biotechnology Co., Ltd. is an enterprise that devotes to the research, development and service of polypeptide. It mainly engages in the polypeptide synthesis for the purpose of scientific research, the research and development of modified polypeptide sample, the development of polypeptide intermediate for drug use and the expansion of industrialized production process. The company commits itself to providing the customers with most complete and high quality products and service, constantly absorbing the most advanced polypeptide synthesis technology and service conception of the world and tries to be your best partner who solves the problem of polypeptide with you jointly. At present, we possess the internationally advanced analytical apparatus and production equipment. We can provide the customers with the service of Level mg-kg polypeptide synthesis and have the production capacity of 200 purified peptides per day. Taishi Biotechnology has stable industrialized production and approximately thirty varieties of polypeptide crude drugs which are under quality control which guarantees our products with high quality and competitive price!
Contact Information
Contact Person Ms. Jessie Wang
Department Marketing
Telephone 86-021-57471766
Fax Number 86-021-57470766
Address Fengxian, Shanghai, China
Fax 86-021-57470766
Zip/Post Code 201406
Website Visit website